Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high875.3 15/03/17
52 week low492.8 16/06/16
52 week change 319.0 (57.37%)
4 week volume8,040,646 04/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Clinigen and Onxeo initiate MA programme in Europe

RNS Number: 1822D Clinigen Group plc 25 April 2017 RNS Reach 25 April 2017 Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL) Clinigen Group plc's (AIM: CLIN, 'Clinigen' or the 'Group') Idis Managed Access ('MA') division and Onxeo S.A (Euronext Paris, Nasdaq Copenhagen: ON...

Holding(s) in Company

RNS Number: 9743C Clinigen Group plc 21 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Clinigen Group Plc Ord GBP 0.01 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights A...

Broker Forecast - Numis issues a broker note on Clinigen Group

Numis today upgrades its investment rating on Clinigen Group (LON:CLIN) to buy (from add) and set its price target at 9...

Clinigen and Diurnal partner for MA programme

Clinigen Group's Idis managed access division and Diurnal Group have partnered to launch a managed access programme...

Clinigen and Diurnal partner for MA programme

RNS Number: 6111Z Clinigen Group plc 16 March 2017 16 March 2017 RNS Reach Clinigen and Diurnal partner for European Managed Access programme for Infacort and Chronocort Clinigen Group plc's (AIM: CLIN, 'Clinigen' or the 'Group') Idis Managed Access (MA) division and Diurnal Group plc (AIM: DNL, 'Diurnal') , have partnered to launch a Managed Acc...

Launch of a European Patient Access programme

RNS Number: 6197Z Diurnal Group PLC 16 March 2017 16 March 2017 Diurnal Group plc ("Diurnal" or the "Company") Diurnal appoints Clinigen to launch a European Patient Access programme for Infacort and Chronocort Infrastructure and supply chain now in place to provide Infacort and Chronocort as unlicensed medicines to patients on a Named Patient b...

Clinigen hikes divi as gross profits rise

Global pharmaceuticals and services company Clinigen's adjusted gross profits rose to 59.1m in the six months to the end of...

Half-year Report

RNS Number: 4819Z Clinigen Group plc 15 March 2017 15 March 2017 STRONG H1 PERFORMANCE WITH ADJUSTED EPS UP 31%* Clinigen Group plc (AIM: CLIN, 'Clinigen' or 'the Group'), the global pharmaceuticals and services company, today publishes its half year results for the six months ended 31 December 2016. FINANCIAL SUMMARY Six months ende...

Fundamental DataMore

P/E ratio73.529
EPS11.9
Dividend yield0.457 %

Equity Research (CLIN)

Clinigen Group Plc
16/03/2017
Magnolia Petroleum (MAGP.L) 0.14p £2.45m US onshore focused oil and gas exploration and production company, announced the results of an independent Reserves Report.  The Report, which is part of the...
edison investment research
Clinigen Group Plc
01/03/2016
Edison Investment Research is terminating coverage on Clinigen Group (CLIN). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be...
edison investment research
Clinigen Group Plc
25/01/2016
Clinigen’s H116 trading statement suggests its business is performing to plan, taking into account some revenue deferrals to H2. The integration of Idis and Link, which we expect to boost its...

Latest discussion posts More

  • Re: Share Price

    Maybe it is is down to President Trump trying to remove obama care with his new healthcare bill, voting later today.
    23-Mar-2017
    bushwhacker
  • Share Price

    Can anyone comment on the decline in the share price? Appreciate any commentary.
    20-Mar-2017
    peterjg1
  • results tomorrow

    .
    14-Mar-2017
    bushwhacker

Users' HoldingsMore

Users who hold Clinigen Group also hold..
GLAXOSMITHKLINE22%
LLOYDS GRP.18%
TELFORD HOMES18%
RDS 'B'18%
BP17%

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN